ADVEGLEE Trademark

Trademark Overview

On Tuesday, October 2, 2018, a trademark application was filed for ADVEGLEE with the United States Patent and Trademark Office. The USPTO has given the ADVEGLEE trademark a serial number of 88139601. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 11, 2021. This trademark is owned by Zydus Pharmaceuticals (USA) Inc.. The ADVEGLEE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders
adveglee

General Information

Serial Number88139601
Word MarkADVEGLEE
Filing DateTuesday, October 2, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 11, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2019

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of oncological related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 10, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZydus Pharmaceuticals (USA) Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPennington, NJ 08534
Party NameZydus Pharmaceuticals (USA) Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPennington, NJ 08523

Trademark Events

Event DateEvent Description
Tuesday, October 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 11, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 15, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 29, 2020EXTENSION 4 GRANTED
Tuesday, December 29, 2020EXTENSION 4 FILED
Tuesday, December 29, 2020TEAS EXTENSION RECEIVED
Saturday, August 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 6, 2020EXTENSION 3 GRANTED
Thursday, August 6, 2020EXTENSION 3 FILED
Thursday, August 6, 2020TEAS EXTENSION RECEIVED
Wednesday, January 22, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 22, 2020EXTENSION 2 GRANTED
Wednesday, January 22, 2020EXTENSION 2 FILED
Wednesday, January 22, 2020TEAS EXTENSION RECEIVED
Friday, August 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2019EXTENSION 1 GRANTED
Wednesday, August 14, 2019EXTENSION 1 FILED
Wednesday, August 14, 2019TEAS EXTENSION RECEIVED
Tuesday, March 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 1, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 1, 2018ASSIGNED TO EXAMINER
Wednesday, October 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 5, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

adveglee related diseases disorders oncological treatment preparations substances pharmaceutical